Supernus Pharmaceuticals, Inc.
Records under this name other than the patents Supernus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 64 patents it holds.
Back to Supernus Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,749,532 | Once Daily Formulations of Tetracyclines now held by TCD Royalty Sub LP In force · High confidence | In force | High confidence | |
| US 11,351,120 | Use of Higher Doses of Modified Release Huperzine Formulations now held by Biscayne Neurotherapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,393,203 | Osmotic Drug Delivery System Term ended Term ended Apr 27, 2026 · High confidence | Term ended | Term ended Apr 27, 2026 | High confidence |
| US 7,611,728 | Osmotic Delivery of Therapeutic Compounds by Solubility Enhancement Term ended Term ended Sep 14, 2025 · High confidence | Term ended | Term ended Sep 14, 2025 | High confidence |
| US 9,744,137 | Topiramate Compositions and Methods of Enhancing Its Bioavailability Lapsed on the fee record Ended Aug 29, 2025 · High confidence | Lapsed on the fee record | Ended Aug 29, 2025 | High confidence |
| US 8,193,211 | Controlled Release Compositions of Gamma-Hydroxybutyrate Lapsed on the fee record Ended Jun 5, 2024 · High confidence | Lapsed on the fee record | Ended Jun 5, 2024 | High confidence |
| US 9,308,176 | Less Abusable Pharmaceutical Preparations Lapsed on the fee record Ended Apr 12, 2024 · High confidence | Lapsed on the fee record | Ended Apr 12, 2024 | High confidence |
| US 8,709,478 | Once Daily Formulations of Tetracyclines now held by TCD Royalty Sub LP Term ended Ended no later than Apr 7, 2024 · Low confidence | Term ended | Ended no later than Apr 7, 2024 | Low confidence |
| US 9,144,551 | Drug Formulations Having Reduced Abuse Potential Term ended Term ended May 12, 2023 · High confidence | Term ended | Term ended May 12, 2023 | High confidence |
| US 7,910,128 | Use of a Mixture of Two or More Enteric Materials to Regulate Drug Release via Membrane or Matrix for Systemic Therapeutics Lapsed on the fee record Ended Mar 22, 2023 · High confidence | Lapsed on the fee record | Ended Mar 22, 2023 | High confidence |